Zivo Bioscience IncOTCQB:ZIVO
- LAST PRICE20.7000
- TODAY'S CHANGE (%)-0.3000 (-1.4286%)
- Bid / Lots18.7000/ 3
- Ask / Lots20.9000/ 3
- Open / Previous Close20.9000 / 21.0000
- Day Range
- 52 Week Range
- Volume493
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZIVO |
|---|---|---|
| 10:42 ET | 200 | 20.9 |
| 11:18 ET | 292 | 20.7 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zivo Bioscience Inc | 74.2M | -4.2x | --- |
Paranovus Entertainment Technology Ltd | 62.6M | -1.1x | --- |
Shineco Inc | 88.3M | 0.0x | --- |
Borealis Foods Inc | 121.2M | -5.0x | --- |
Australian Oilseeds Holdings Ltd | 21.6M | -1.9x | --- |
Pineapple Inc | 16.1M | 2.0x | --- |
Company Information
Zivo Bioscience, Inc. is a research and development company. The Company operates in both the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its product candidates are at different stages of development for different applications. It is developing a product candidate targeting poultry gut health. It is developing products for Bovine Mastitis, Canine Joint Health, Human Immune Modulation, Algal biomass for human consumption, and Biomass for supporting skin health/anti-aging. It is focused on licensing and selling natural bioactive ingredients derived from their proprietary algae cultures to animal, human and dietary supplement, and medical food manufacturers.
Contact Information
- Headquarters
- 21 E. Long Lake Road, Suite 100BLOOMFIELD HILLS, MI, United States 48304
- Phone
- 248-452-9866
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Office, Director
- John Payne
- Chief Financial Officer
- Keith Marchiando
- Director
- Laith Yaldoo
- Independent Director
- Alison Cornell
- Independent Director
- Christopher Maggiore
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $74.2M |
|---|---|
Revenue (TTM) | $79.0K |
Shares Outstanding | 3.5M |
Zivo Bioscience Inc does not pay a dividend. | |
Beta | 0.20 |
EPS | $-4.90 |
Book Value | $-0.93 |
P/E Ratio | -4.2x |
Price/Sales (TTM) | 939.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -17,289.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
